Scarica l'app Stockscreener
1.0682
2.89%
-0.0318
Precedente Chiudi:
$1.10
Aprire:
$1.1
Volume 24 ore:
41,781
Relative Volume:
0.02
Capitalizzazione di mercato:
$9.20M
Reddito:
$1.52M
Utile/perdita netta:
$-13.97M
Rapporto P/E:
-0.3502
EPS:
-3.05
Flusso di cassa netto:
$-13.29M
1 W Prestazione:
+5.76%
1M Prestazione:
+11.27%
6M Prestazione:
+44.33%
1 anno Prestazione:
-38.61%
Intervallo 1D:
$1.06
$1.105
Intervallo di 1 settimana:
$1.00
$1.19
Portata 52W:
$0.55
$3.06
Predictive Oncology Inc Stock (POAI) Company Profile
Nome
Predictive Oncology Inc
Settore
Industria
Telefono
412-432-1500
Indirizzo
91 43RD STREET, PITTSBURGH, MN
Confronta POAI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
POAI
Predictive Oncology Inc
|
1.0682 | 9.20M | 1.52M | -13.97M | -13.29M | -3.05 |
|
ISRG
Intuitive Surgical Inc
|
562.68 | 190.13B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
88.00 | 47.48B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
171.86 | 47.33B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
247.34 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
79.67 | 16.11B | 3.93B | 415.40M | 384.70M | 2.06 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Iniziato | H.C. Wainwright | Buy |
Predictive Oncology Inc Borsa (POAI) Ultime notizie
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies - GlobeNewswire
Predictive Oncology (POAI) Projected to Post Earnings on Tuesday - Defense World
Head-To-Head Review: Pathfinder Cell Therapy (OTCMKTS:PFND) versus Predictive Oncology (NASDAQ:POAI) - Defense World
Predictive Oncology (NASDAQ:POAI) Stock Price Passes Below Two Hundred Day Moving Average – Here’s Why - Defense World
Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire) - Aktiellt
Predictive Oncology (POAI) Advances in Drug Repurposing with AI Innovations | POAI Stock News - GuruFocus
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs - GlobeNewswire
Revolutionary AI Platform Revives Abandoned Cancer Drugs with Stunning Results - Stock Titan
Predictive Oncology Ends Merger Talks with Renovaro - TipRanks
Renovaro says Predictive Oncology terminates merger transaction - MSN
Health Care Stocks Tumble On Multiple Fronts - Finimize
Renovaro Biosciences faces merger setback with Predictive Oncology By Investing.com - Investing.com Canada
Renovaro Biosciences faces merger setback with Predictive Oncology - Investing.com India
Renovaro Says Predictive Oncology Terminates Merger Transaction With Co - marketscreener.com
Renovaro BioSciences (RENB) Challenges Merger Termination - GuruFocus
Renovaro Biosciences Announces Breach Of Agreement By Predictive Oncology, Legal Action Pending - Nasdaq
Renovaro Says Predictive Oncology Terminates Merger Deal; Shares Fall - MarketScreener
Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewswire
Merger Crisis: Renovaro Threatens Legal Action After Predictive Oncology Backs Out - Stock Titan
Predictive Oncology Reports 2024 Financial Results and Merger Plans - TipRanks
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Predictive Oncology pushing forward with Renovaro merger despite $10.8M loss in 2024 - The Business Journals
Predictive Oncology Advances AI Merger Plans Despite $10.8M Loss: Key Strategic Moves Revealed - Stock Titan
Predictive Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research - Insider Monkey
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Predictive Oncology developed predictive models from 21 compounds from NPDC - TipRanks
Predictive Oncology Successfully Develops Predictive Models - GlobeNewswire
Predictive Oncology (POAI) Stock Surges Following Major Drug Discovery Breakthrough - Stocks Telegraph
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - The Manila Times
Predictive Oncology Develops Advanced Predictive Models for Natural Compounds in Cancer Drug Discovery - Nasdaq
Milestone Merger Payment with Predictive Oncology to Advance AI - newschannelnebraska.com
Predictive Oncology Sells Skyline Medical Assets To DeRoyal Industries - Nasdaq
Predictive Oncology Sells Skyline Medical Assets to DeRoyal Industries - citybiz
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries to Focus on AI-Driven Drug Discovery - Nasdaq
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewswire
Strategic Pivot: Predictive Oncology Divests Medical Assets for AI-Powered Future - Stock Titan
Predictive Oncology (POAI) Expected to Announce Earnings on Thursday - Defense World
Predictive Oncology to launch ChemoFx assay in Europe - MSN
Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report -
Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Insider Monkey
Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals
MarketsMedicine Hat News - Financial Content
Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail
Milestone Merger Payment made with Predictive Oncology - openPR
Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire
Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times
Renovaro completes first milestone payment for Predictive Oncology deal - TipRanks
Predictive Oncology Inc Azioni (POAI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):